For the year ending 2025-12-31, XLO has $154,685K in assets. $119,412K in debts. $137,531K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 137,531 | |||
| Collaboration and license agreement receivable | 5,000 | |||
| Prepaid expenses and other current assets | 2,496 | |||
| Total current assets | 145,027 | |||
| Restricted cash | 1,807 | |||
| Property and equipment | 12,645 | |||
| Less accumulated depreciation | 8,753 | |||
| Property and equipment, net | 3,892 | |||
| Operating lease right-of-use asset | 3,959 | |||
| Total assets | 154,685 | |||
| Accounts payable | 3,168 | |||
| Accrued expenses | 11,739 | |||
| Deferred revenue, current portion | 40,023 | |||
| Operating lease liability, current portion | 1,343 | |||
| Total current liabilities | 56,273 | |||
| Deferred revenue, net of current portion | 20,635 | |||
| Operating lease liability, net of current portion | 5,611 | |||
| Common stock warrant liabilities | 29,560 | |||
| Liabilities to issue common stock | 7,333 | |||
| Total liabilities | 119,412 | |||
| Additional paid-in capital | 454,062 | |||
| Accumulated deficit | -418,789 | |||
| Total stockholders' equity | 35,273 | |||
| Total liabilities and stockholders' equity | 154,685 | |||
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)